Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Blucora Inc is an asset management business based in the US. Blucora shares (BCOR) are listed on the NASDAQ and all prices are listed in US Dollars. Blucora employs 1,100 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $18.81 |
|---|---|
| 52-week range | $14.51 - $21.40 |
| 50-day moving average | $17.77 |
| 200-day moving average | $17.64 |
| Wall St. target price | $25.50 |
| PE ratio | 60.6774 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $0.31 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $18.81 from 2022-07-01
| 1 week (2022-06-29) | 1.40% |
|---|---|
| 1 month (2022-06-02) | 3.98% |
| 3 months (2022-04-06) | -0.05% |
| 6 months (2022-01-06) | 8.73% |
| 1 year (2021-07-06) | 10.58% |
|---|---|
| 2 years (2020-07-06) | 60.22% |
| 3 years (2019-07-05) | 29.71 |
| 5 years (2017-07-05) | 20.35 |
Valuing Blucora stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Blucora's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Blucora's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 61x. In other words, Blucora shares trade at around 61x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Blucora's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.6695. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Blucora's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Blucora's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $100.2 million.
The EBITDA is a measure of a Blucora's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $914.4 million |
|---|---|
| Operating margin TTM | 7.09% |
| Gross profit TTM | $405.3 million |
| Return on assets TTM | 3.68% |
| Return on equity TTM | 4.25% |
| Profit margin | 1.61% |
| Book value | $7.36 |
| Market capitalisation | $888.7 million |
TTM: trailing 12 months
We're not expecting Blucora to pay a dividend over the next 12 months.
Blucora's shares were split on a 1:10 basis on 12 September 2002. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Blucora shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Blucora shares which in turn could have impacted Blucora's share price.
Over the last 12 months, Blucora's shares have ranged in value from as little as $14.51 up to $21.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Blucora's is 1.4383. This would suggest that Blucora's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Blucora, Inc. provides technology-enabled financial solutions to consumers, small business owners, tax professionals, financial advisors, and certified public accounting firms in the United States. The company operates through two segments, Wealth Management and Tax Preparation. The Wealth Management segment offers an integrated platform of brokerage, investment advisory, and insurance services to financial advisors. The Tax Preparation segment provides digital do-it-yourself tax preparation solutions through TaxAct. com; and ancillary services, including refund payment transfer, audit defense, stored value cards, retirement plan services, and e-filing services. This segment also offers professional tax preparer software that allows professional tax preparers to prepare and file individual and business returns.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.